ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2320

Nailfold Videocapillaroscopy Findings in Patients with Psoriatic Disease: Is There a Distinctive Psoriatic Pattern?

Eduardo Briones-García1, Tatiana Sofía Rodríguez-Reyna2, Eduardo Martin Nares2, Guillermo A Guaracha-Basañez3 and Iris Paola García Herrera4, 1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Immunology and Rheumatology Department., Ciudad de México, Distrito Federal, Mexico, 2Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 3Instituto Nacional de Ciencias Medicas y Nutricion “Salvador Zubirán”, Mexico City, Distrito Federal, Mexico, 4Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Meeting: ACR Convergence 2024

Keywords: Dermatology, Disease Activity, Psoriatic arthritis, skin

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The utility of nailfold videocapillaroscopy (NVC) in conditions such as systemic sclerosis and primary Raynaud´s phenomenon is well known. Whether patients with psoriatic disease (PsD) have specific findings in NVC is not well stablished. We aimed to evaluate findings on NVC in patients with psoriatic disease and their association with clinical features.

Methods: This was a cross-sectional study that included patients with PsD (Pso according to a dermatologist and PsA according to CASPAR criteria). As a control group, we included healthy individuals. The disease activity was evaluated using PASI, NAPSI, and DAPSA scores.

NVC was performed using an optical probe equipped with a 200x contact lens (Optilia) connected to and image analysis software (Videocal, DS Medica, Milan, Italy). Four fields from each finger were obtained from the second to fifth finger of each hand. The following NVC parameters were retrieved: capillary density,  overall nailfold architecture, normal capillaries (hairpin shaped), non-specific capillary variations of morphology (tortuous, crossed or bushy capillaries), and major abnormalities, including dilated and giant capillaries, microhemorrhages, neo-angiogenesis, and avascular areas. According to the capillaroscopic parameters, we assessed for NVC patterns: normal, unusual/atypical and scleroderma patterns (‘early’, ‘active’ and ‘late’ patterns).

Results: We included 39 patients with PsD, including 29 with PsA and 10 with Pso, and 28 healthy controls. Twenty-four (61.5%) had psoriasis activity according to PASI and 16 (55.2%) had active PsA according to DAPSA. Twenty-three (58.9%) had nail psoriasis.

Patients in the PsD group have more frequently major NVC abnormalities compared to the healthy group (74.4% vs. 35.7%, p=0.002) (Table 1, Figure 1). In the PsD group, there was a higher frequency of abnormal nailfold architecture (35.9% vs. 0%, p< 0.001), crossed (94.9% vs. 78.6%, p=0.04), bushy (74.4% vs. 7.1%, p< 0.001), and dilated capillaries (56.4% vs. 10.7%, p< 0.001), microhemorrhages (30.8% vs. 3.6%, p=0.005) and avascular areas (48.7% vs. 0, p< 0.001) and less frequently exhibited a normal pattern (5.1% vs. 39.3%, p< 0.001). Only in PsD group there were cases of scleroderma patterns. Nine (23.1%) patients with PsD exhibited a NVC pattern (‘psoriatic pattern’) consisting in a bordering low capillary density, frequent bushy capillaries with a distinctive morphology (like the ‘basket-like’ morphology described in psoriatic plaques), and avascular areas. The mean capillary density correlated negatively with de DAPSA score (rho: -0.39, p=0.03)

There were no differences in the frequency and types of NVC abnormalities between patients with PsA and those with Pso, between those with and without nail Pso, or according to the presence of active skin or articular disease.

Conclusion: Major NVC abnormalities are frequent in PsD. PsA and Pso patients exhibited the same frequency and types of NVC abnormalities, irrespective of activity status and presence of nail involvement. A pattern consisting in bordering low capillary density, frequent distinctive bushy capillaries and avascular areas may be regarded as a ‘psoriatic pattern’.

Supporting image 1

Representative images of NVC in psoriatic disease. A: normal atypical pattern with frequent crossed capillaries. B: Multiple microhemorrhages. C and D: ‘Psoriatic pattern’: multiple bushy capillaries with a basket-like appearance, borderline low capillary density and avascular áreas

Supporting image 2

NVC abnormalities in psoriatic disease compared to the healthy group


Disclosures: E. Briones-García: None; T. Rodríguez-Reyna: None; E. Martin Nares: None; G. Guaracha-Basañez: None; I. García Herrera: None.

To cite this abstract in AMA style:

Briones-García E, Rodríguez-Reyna T, Martin Nares E, Guaracha-Basañez G, García Herrera I. Nailfold Videocapillaroscopy Findings in Patients with Psoriatic Disease: Is There a Distinctive Psoriatic Pattern? [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/nailfold-videocapillaroscopy-findings-in-patients-with-psoriatic-disease-is-there-a-distinctive-psoriatic-pattern/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nailfold-videocapillaroscopy-findings-in-patients-with-psoriatic-disease-is-there-a-distinctive-psoriatic-pattern/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology